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Soren SondergaardAbstract
Hemodynamic management of critically ill patients in
the ICU or high-risk patients in the operating room has
paradoxically shown progress in terms of outcome after
the systematic application of volume responsiveness/
flow optimization based on pulse pressure variation
and/or stroke volume variation during controlled,
positive-pressure ventilation in patients without
spontaneous respiratory efforts. This assessment of
circulatory optimization should ideally be based on an
exhaustive, predictive and coherent physiological
understanding of the cardiovascular system model. This
paper sketches the extremely complex physiological
background of the concept of volume responsiveness,
concluding that it is not a reliable means of guiding
hemodynamic optimization because it is based on a
nonexhaustive, nonpredictive and incoherent
physiological model.or a nonresponder to VE in terms of increase in CO. PPVI wonder if the gentleman in the audience who denounces
PPV still uses leeches in his practice? (Lecturer in reply to
question concerning pulse pressure variation at ESICM
Congress in Paris 2012)Introduction
Pulse pressure variation (PPV) is promoted in the literature
and at international meetings as a means of optimizing flow
in patients subjected to correction of hemodynamic param-
eters in intensive care or in the operating room. Perel and
colleagues [1] extended the work of Morgan and colleagues
[2] and introduced the concept of systolic pressure vari-
ation, analyzing the relation of dUp and dDown in response
to positive-pressure ventilation and intravascular volume
expansion (VE). Focus shifted from systolic pressure to the
amplitude of arterial pressure and the variation induced by
positive-pressure ventilation [3]. Investigations into PPV
have increased dramatically since 2000 (see Figure 1).Correspondence: sondergaard.soren@gmail.com
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© BioMed Central Ltd.2013The majority of studies have shown a distinct relation-
ship between PPV and the prospect of increasing cardiac
output (CO) by VE. Michard and Teboul suggested an
explanation for this: PPV is seen as a reflection of the
patient’s heart function on the Starling curve, responding
to VE (diminishing PPV) if on the ascending limb and
nonresponding (no change in PPV) if on the level part of
the cardiac function curve [4] (see Figure 2).
PPV is calculated according to the following equation:
PPV ; % ¼ PPmax−PPminð Þ  100
PPmax þ PPminð Þ  0:5 ð1Þ
where PPmax is maximum pulse pressure and PPmin
is minimum pulse pressure. Usually a threshold value
(derived from analysis of receiver operating characteris-
tics) of PPV >12 to 16% is applied for the binary decision
of whether the patient may be expected to be a responder
is a dynamic parameter in the sense that it demands an
excitation of the cardiopulmonary system to deliver the
signal of variation in pressure amplitude. The excitation is
the cyclic variation in pleural pressure in positive-pressure
ventilation. PPV has a number of related, derived dynamic
measures: pulsoximetric plethysmographic variation,
stroke volume variation, variation of the electrocardiog-
raphy pre-ejection period, and a number of dynamic
parameters derived from echocardiographic examination
(for example, inferior caval vein diameter and collapsibil-
ity, left ventricular end diastolic area, respiratory variation
of velocity time index of right and left ventricle or
response of these measures to passive leg raising).
These measures may be regarded conceptually as system
excitation–system response, the cardiopulmonary system
representing a black box. In the following, PPV is used as
an example for elucidation of some of the physiological
mechanisms and to expose the contents of the black box.
The reader is further referred to the excellent review by
Magder including repository figures [5] and to Michard and
colleagues’ correspondence following Magder’s review [6].
Figure 1 Number of publications on pulse pressure variation
increases year by year.
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The working principle of PPV will be elucidated on the
background of the combined venous return (VR) and car-
diac function curves (see [7]). A cyclic change in pleural
pressure is generated in positive-pressure ventilation, in-
creasing during insufflation and waning during expiration.
With each unit increase in pleural pressure, VR is inhib-
ited by way of the transient increase in central venous
pressure (CVP) or right atrial pressure (RAP). Depending
on pulmonary compliance, the increase in pleural pressure
increases RAP proportionally 1 mmHg per 3 mmHg
insufflation pressure [8,9]. This decreases the difference
from the mean systemic filling pressure (Pms – RAP). This
difference is one determinant of VR and, in turn, CO. Pms
is affected by the cyclic change in pulmonary pressureFigure 2 Increase in cardiac output in response to volume
expansion representing preload. Patient’s position on the Starling
cardiac function curve as an explanation for the increase in cardiac
output (CO/Q) in response to volume expansion representing preload.[10] and adapts to a constant increase as in positive
end-expiratory pressure (PEEP) [11]. Decreasing differ-
ence (Pms – RAP) diminishes the right ventricular stroke
volume (RVSV) in the volume-responsive patient (in the
words of the PPV concept), whereas this is not the case in
the nonresponsive patient. This is illustrated in Figure 3.
Circulatory factors
One should contemplate the factors governing transmis-
sion of varying RVSV to variation in arterial pressure. As a
first step, RAP is dissipated in two impedances, the resist-
ance of the tricuspid valve and the elastance of the right
ventricle. The right ventricular pressure, in turn, is dissi-
pated into resistance of the pulmonary valve and the com-
pliance and resistance of the pulmonary circulation – in
short, the varying VR is manifested as pressures in four
chambers depending on their elastances, as flow in four
valves depending on their resistances and as pressure and
flow in two vascular systems (pulmonary, systemic)
depending on their compliances and resistances. If any-
thing abnormal is occurring in any of these 10 relay
stations, the signal will be distorted in unpredictable and
undetectable ways.
Wyler von Ballmoos and colleagues demonstrated how
pulmonary hypertension and right ventricular dysfunction
in postcardiac and septic patients invalidated the determin-
ation of volume responsiveness [12]. The Bern group repli-
cated this finding in an endotoxemic animal model,
although still speculating about the relative contribution of
pulmonary hypertension and right ventricular failure [13].
Michard and colleagues suggested that this lack of effi-
ciency of PPV helped the clinician suspect right ventricular
failure [14], and Mahjoub and colleagues recommended
that the peak systolic velocity of tricuspid annular motion
be assessed by tissue Doppler echocardiography in patients
with PPV >12% to detect false-positive PPV due to
right ventricular dysfunction before fluid challenge [15].
Mesquida and colleagues likewise demonstrated in a canine
study that PPV decreased when cardiac contractility was
depressed by β-blockade, mimicking heart failure [16].
The pulmonary circulation acts as a capacitance vessel
and the time-varying RVSV is subjected to at least three
mechanisms during the passage from right to left heart
through the pulmonary circulation. First, pleural pressure
increases afterload on the right ventricle and preload on the
left ventricle during insufflation. The impact of varying
pleural pressure on the left atrium and left ventricle is
minor compared with the effect on the right atrium and
right ventricle because the pulmonary vasculature, left
atrium and left ventricle are equally affected by the pleural
pressure but the encroachment on right ventricular volume
by the insufflation pressure increases left ventricular
diastolic compliance. Second, during inspiration blood is
squeezed from the pulmonary venous circulation to the left
Figure 3 Difference between mean systemic filling and right atrial pressure correlates with venous return. With increasing pleural
pressure (Ppl) during inspiration, right atrial pressure (RAP) increases, diminishing the difference between mean systemic filling and right atrial
pressure (Pms – RAP). CO/Q, increase in cardiac output; VR, venous return.
Sondergaard Critical Care Page 3 of 62013, 17:327
http://ccforum.com/content/17/6/327atrium. Finally, the passage of the RVSVs is determined by
the cardiopulmonary transit time (CPTT), also known as
the mean transit time. Michard and Teboul indicated that
the changes in RVSV are transmitted ‘après un délai de
deux à trois battements cardiaques en raison du temps de
transit sanguin pulmonaire prolongé’ [17]. The CPTT, how-
ever, is anywhere from 4 to 14 seconds [18]. The CPTT/
mean transit time is dependent on the pulmonary blood
volume, stroke volume and heart rate. These mechanisms
have been summarized in rich detail by Robotham and col-
leagues in canine experiments with closed chest and intact
heart and in a right heart bypass model [19]. With regard
to the second item above, they noted that the increase in
left ventricular stroke volume in certain conditions of PEEP
and volume state was asynchronous with the increase in
esophageal pressure (a surrogate for pleural pressure) and
that other mechanisms must be at play. Robotham and col-
leagues included the respiratory rate, inspiratory/expiratory
ratio, functional residual capacity, tidal volume, pulmonary
blood volume and pulmonary vascular compliance as deter-
minants for the arterial pressure amplitude. Consequently,
the sequence of RVSVs per inspiratory/expiratory cycle
may arrive in or out of phase with the respiratory rate and
result in constructive or destructive interference. This
phenomenon was illustrated by De Backer and colleagues
[20] in accordance with the prediction of Robotham and
colleagues.
A seemingly unexplored field is the establishment of
threshold values for PPV dependent on age. As Magder
notes: ‘aortic elastance varies with age and disease and so
will the relationship of stroke volume to pulse pressure.
For a given Q, stroke volume also varies with heart rate
and therefore so will pulse pressure. Thus, the relationship
of stroke volume to pulse pressure varies widely in the
population, and this greatly limits quantitative predictions’
[5]. Almost needless to say, the PPV concept only works
for patients in sinus rhythm. Worth noting is that the
occasional patient with ventricular premature complexes
followed by compensatory pause opens the interesting
opportunity to calculate the CPTT by analyzing arterial
pressure amplitude (personal observation).Pulmonary factors
Mechanics of the pulmonary system add to the complexity
of transmission. de Waal and colleagues thus demon-
strated, unsurprisingly, that the PPV concept does not
work in open chest conditions because no pleural pressure
changes are generated [21]. Undeniably, the patient must
be without spontaneous respiratory effort as this interferes
with the controlled, cyclic variation in intrathoracic
pressure. If necessary, the patient must be heavily sedated
or muscle relaxed, adding the onus of critical illness
myopathy to critical disease.
The excitation must attain a pressure large enough to
affect VR. This has been documented by several investiga-
tors, thus Muller and colleagues stated that the insuffla-
tion pressure must exceed 20 cmH2O for the threshold
value of 13% to be validly indicating volume responsive-
ness [22] and De Backer and colleagues argued that the
tidal volume must exceed 8 ml/kg for PPV to reliably indi-
cate volume responsiveness at a threshold value of 12%
[23]. Mesquida and colleagues [16] replicated this finding
by measuring PPV at increasing tidal volumes (5, 10, 15,
and 25 ml/kg) with resultant increasing PPV. The same
group decreased thoracic wall compliance (and, as a corol-
lary, total compliance) by restricting chest wall motion,
again increasing PPV and changing the threshold value.
Schmitt and colleagues demonstrated respiratory varia-
tions in the right ventricular stroke index estimated from
the right ventricle outflow tract (respiratory variation of
velocity time index of right ventricle) between 10 and 26%
related to PEEP in human studies mirroring PEEP-
dependent RVSV as described in the above references
[24]. Magder pointed out that lung compartments in West
zone II (Pa > PA > Pv) during intermittent positive pressure
ventilation (IPPV) decrease RVSV and cause significant
PPV, but that this is unconnected to the volume state [25].
Renner and colleagues demonstrated that PPV was still
valid in patients with increased abdominal pressure [26] –
but the cutoff value was ≥20.5%! Freitas and colleagues
described a threshold of 6.5% in PPV in septic patients
ventilated in lung-protective mode with high PEEP [27].
Other thresholds are published in well circumscribed
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leagues likewise described the effects of PEEP and called
for a standardization of ventilatory settings when assessing
volume responsiveness by PPV [29].
Recently, interest has been devoted to the phenomenon
of respiratory sinus arrhythmia (see [30]). Respiratory
sinus arrhythmia manifests in spontaneously breathing
subjects as an increase in heart rate during inspiration and
a decrease during expiration (positive respiratory sinus
arrhythmia). This pattern is partly reversed, partly
abolished in controlled IPPV (negative respiratory sinus
arrhythmia). The impact of negative respiratory sinus
arrhythmia dependent on ventilator settings and the
hemodynamic state still has to be described.
Experimental studies in pulse pressure variation
The documentation for the use of PPV usually is headed
as prediction of volume responsiveness based on a strict
protocol involving a baseline measurement of PPV/CO
after 10 to 15 minutes of stable condition in terms of heart
rate, CO, mean arterial pressure and vasoactive and cardi-
oactive medication followed by VE, usually 250 to 500 ml
colloid, delivered in 5 to 15 minutes followed by another
calculation of PPV/CO, in total up to 30 minutes where
nothing else can happen in terms of anesthetic manage-
ment, surgical procedure or intensive care. Add to this the
time course for the viscoelastic characteristics of the cir-
culation to reach a new equilibrium [31]. This procedure
demands some patience on the behalf of the surgeon to
have his work interrupted for repeated 30-minute periods,
and should anything happen during this interval affecting
RAP, mean arterial pressure or CO, the measurement
sequence is invalidated because this will affect the differ-
ence (Pms – RAP) and VR. Gelman enumerates at least
eight variables affecting CVP: intra-abdominal pressure,
cardiac pump function, pericardial pressure, pulmonary
arterial pressure, venous resistance, intrathoracic pressure,
stressed/unstressed volume and hypovolemia [32]. None
of these can change during the 30-minute assessment of
PPV! Three other characteristics of the PPV sequence are
worth noticing. First, PPV can be eliminated by 5 to
10 mg ephedrine and established by a modest infusion of
nitroglycerine – changing the effective circulating volume,
also known as stressed volume. This distinction between
stressed and unstressed volume, however, is absent from
the PPV concept. Cecconi and Rhodes, as a rare exception,
drew attention to the fact that vascular tone may change
during the volume challenge, invalidating the assessment
of volume responsiveness [33]. Second, the fluid bolus
must be standardized according to patient characteristics
and vascular compliance (the suggestion of Smith and
colleagues [29] to standardize ventilatory settings). Finally,
and most importantly, PPV does not provide an assess-
ment of optimum flow; it provides an estimate of whetherflow can be increased by VE. The decision is binary de-
fined by a threshold value derived from receiver operating
characteristic analysis, although this has recently been
slightly modified by the introduction of ‘gray zones’ (see
Cannesson and colleagues [34] and Le Manach and col-
leagues [35]). Nothing is predicated of the patient’s need
for increased flow. There is general agreement on this (see
Magder [5,25], Pinsky [36], Takala [37]). The threshold
value is chosen to represent the – perceived – best com-
bination of sensitivity and specificity, and considerations
of cost/benefit of threshold are absent.
The PPV assessment is dependent on ventilatory settings,
vasoactive and cardioactive medication. This may have
induced the negative outcome of a study of goal-directed
therapy: physically fit patients were volume resuscitated
after induction of anesthesia – which rendered them
volume responsive – but were not in need of volume. The
surplus volume caused all of the well-known complications
in the postoperative period (see Challand and colleagues
[38]). A similar interpretation is possible in a study by
Bundgaard-Nielsen and colleagues, who estimated the
functional intravascular volume deficit in anesthetized
patients by maximizing volume according to PPV <10%
[39]. The volume resuscitation was interpreted as the
functional intravascular volume deficit. Physiologically
intravascular volume was demobilized to an unstressed
state by anesthetic vasodilation.
Pinsky described the incorporation of PPV into functional
hemodynamic monitoring in circulatory unstable patients:
‘If a patient responds to volume challenge or any equivalent
preload responsiveness tests [PPV, plethysmographic vari-
ation in IPPV, variations in CVP in spontaneous ventilation,
passive leg raising], then volume resuscitation should be
initiated. In preload responsive patients who, despite in-
crease in CO in response to fluid resuscitation, cannot
maintain an adequate perfusion, a decrease in vascular tone
should be suspected and vasopressors should be given in
addition to fluids. If a hypotensive patient is neither preload
responsive nor exhibiting reduced vasomotor tone, then
the problem is the heart or an obstruction in blood flow
such as thromboembolic events’ [36]. This is the sequential
approach to resuscitation. The suggested volume challenge
carries a success rate of approximately 50% in terms of
increase in CO and an undeclared risk of volume
overloading the patient, as summarized by Marik and col-
leagues: ‘Whereas under-resuscitation results in inadequate
organ perfusion, accumulating data suggest that over-
resuscitation increases the morbidity and mortality of critic-
ally ill patients’ [40]. Still, nine years later, nobody has
answered Professor Pinsky’s call: ‘No study yet published
has prospectively predicted which patients would be
preload responsive based on these measures and then
shown that their predictions were correct’ [41]. The choice
of therapy, alternatively, may be supported by performing
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would obviate the need for CO measurement. So on the
one hand there is a volume challenge with a 50% chance of
improving CO and an unknown risk of overloading the pa-
tient, and on the other there is a preload responsiveness test
based on complex cardiopulmonary interaction – and nei-
ther approach answers the question of why the patient is
circulatory unstable or whether the patient is in need
of volume for optimization. MacLean and Duff in [42]
argued the case for CVP in volume resuscitation in shock,
adducing three causes for circulatory instability: cardiac fail-
ure, volume deficit and peripheral vascular failure. We may
think differently about the utility of CVP, but the three
causes stand the test of time (see Payen [43]). Alternatively,
the simultaneous measurement of CO, mean arterial pres-
sure and CVP readily allows for clinical assessment of
whether the cause is cardiac function, volume state and/or
vasomotor tone. These factors are the determinants of car-
diovascular function and, in a more comprehensive cardio-
vascular model, are obvious candidates for studying the
simultaneous and judicious use of volume, vasoactive and
cardioactive drugs in contrast to the sequential application
in functional hemodynamic monitoring. This seems to be a
reasonable venue of research in managing circulatory insta-
ble patients in surgery and intensive care.
In summary, PPV (and other reflections of cardiopul-
monary interaction) is heralded as an assessment of opti-
mizing the volume and flow state of patients in anesthesia
and intensive care by analyzing variations in pressure
amplitude as elicited by IPPV. From carefully controlled
studies a threshold value is derived for the optimal sensi-
tivity and specificity, and the clinician arrives at a binary
decision of whether to expand volume. Firstly, the concept
does not provide an optimum of volume/flow and all
agree that a patient may be volume responsive but not in
need of volume. Next, the concept is weighed down by
the most intricate physiology of cardiopulmonary inter-
action, which makes it impossible to ascertain whether a
positive or a negative result of the PPV calculation actually
indicates volume responsiveness. Third, the literature
abounds in threshold values defined in various patient
populations under various conditions spanning from 6 to
20%. Finally, the subject is an exceptional demonstration
of physiology but hardly guides the management of
critically ill patients.
Proposed checklist before performing volume
expansion suggested by PPV
✓ Is the patient ventilated with IPPV without spontaneous
efforts?
✓ Is the patient ventilated in nonprotective ventilation
(tidal volume at least 8 ml/kg)?
✓ Is the patient in sinus rhythm?✓ Is chest wall compliance normal (thorax closed, no
flail chest, no binding)?
✓ Is the patient unaffected by valvular disease?
✓ Is the patient unaffected by right ventricle and/or left
ventricle dysfunction (for example, as assessed by an
echocardiographic examination including measurement
of peak systolic velocity of tricuspid annular motion
assessed by tissue Doppler echocardiography)?
✓ Does the patient have normal abdominal pressure?
✓ Have you decided or have you performed a calibration
to decide which threshold value (6 to 20.5%) should be
used for the binary decision of volume responsiveness?
✓ Have you established the compliance of the patient’s
vascular capacitance in order to standardize the VE?
✓ Have you established that the patient’s heart rate/
respiratory rate ratio is ≥3.6?
✓ Can you safely establish a baseline, perform a volume
challenge and remeasure without any factors affecting
heart efficiency and/or vasomotor tone during the
assessment?
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